Cathie Wood’s ARK ETFs have disclosed their daily trades for Monday, March 31st, 2025, making notable adjustments to their investment portfolio. The most significant transaction of the day involved the purchase of 230,925 shares of GitLab Inc (NASDAQ:GTLB), with a total dollar value of $11,172,151. This move indicates a bullish stance on the software development platform by ARK, with the majority of shares, 178,102, acquired through the ARKK ETF and the remaining 52,823 through the ARKW ETF.
In addition to GitLab, ARK made a substantial investment in CoreWeave Inc (NASDAQ:CRWV), buying 98,159 shares for a total value of $3,926,360, exclusively through the ARKW ETF. This follows a previous purchase of CoreWeave shares last Friday, suggesting a growing interest in the cloud computing company.
The investment firm also increased its stake in the biotech sector, purchasing shares of Beam Therapeutics Inc (NASDAQ:BEAM), Crispr Therapeutics AG (NASDAQ:CRSP), Intellia Therapeutics Inc (NASDAQ:NTLA), and Tempus AI Inc (NASDAQ:TEM), with total dollar values of $3,302,626, $3,049,085, $3,226,740, and $2,404,462 respectively. The trades were split between the ARKK and ARKG ETFs, highlighting ARK’s continued focus on genomic innovation.
On the sell side, ARK made a significant divestment from UiPath Inc (NYSE:PATH), offloading 1,799,069 shares across three ETFs (ARKK, ARKW, and ARKF) for a total dollar value of $19,232,046. This sale represents the largest dollar-value trade of the day and may signal a strategic shift away from the robotic process automation company.
Other sales included shares of Prime Medicine Inc (NASDAQ:PRME), Repare Therapeutics Inc (NASDAQ:RPTX), Unity Software Inc (NYSE:U), Veracyte Inc (NASDAQ:VCYT), and Veeva Systems Inc (NYSE:VEEV), with ARK divesting from these stocks at varying quantities and total dollar values.
The report also indicates smaller, yet strategic trades such as the acquisition of 31,731 shares of Robinhood Markets Inc (NASDAQ:HOOD) through the ARKK ETF, totaling $1,330,163. This follows a larger purchase of Robinhood shares on the previous Friday, suggesting a growing position in the brokerage firm.
Investors following ARK’s movements can observe patterns in the fund’s trading behavior, with consistent buying in certain sectors like biotech and cloud computing, while selectively reducing positions in other areas. These daily trade disclosures offer insights into the active management strategy employed by Cathie Wood’s ARK ETFs, as they adapt to market conditions and pursue growth opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.